| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.4 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |